China Medical & HealthCare Group Limited provided earnings guidance for the six months ended 30 June 2020. For the period, the company expected to record a loss attributable to shareholders of the Company for the six months ended 30 June 2020 in the range of approximately HKD 47 million to HKD 67 million as compared with a net profit of approximately HKD 12.2 million for the corresponding period in 2019. This was mainly due to (i) the decrease of revenue from the operations of the Healthcare Division and the Eldercare Division as affected by the negative impacts from the on-going COVID-19 pandemic; (ii) no interest income from the money lending business; and (iii) a loss in fair value change of investments held for trading compared with a gain recorded in corresponding period in 2019.